| Literature DB >> 33420237 |
Yusuke Adachi1, Arihiro Kiyosue2, Jiro Ando1, Takuya Kawahara3, Satoshi Kodera1, Shun Minatsuki1, Hironobu Kikuchi1, Toshiro Inaba1, Hiroyuki Kiriyama1, Kazutoshi Hirose1, Hiroki Shinohara1, Akihito Saito1, Takayuki Fujiwara1, Hironori Hara1, Kazutaka Ueda1, Kenichi Sakakura4, Masaru Hatano1,5, Mutsuo Harada1, Eiki Takimoto1, Hiroshi Akazawa1, Hiroyuki Morita1, Shin-Ichi Momomura4, Hideo Fujita1,4, Issei Komuro1.
Abstract
Percutaneous coronary intervention (PCI) is sometimes considered as an alternative therapeutic strategy to surgical revascularization in patients with coronary artery disease (CAD) and reduced left ventricular ejection fraction (LVEF). However, the types or conditions of patients that receive the clinical benefit of left ventricular reverse remodelling (LVRR) remain unknown. The purpose of this study was to investigate the determinants of LVRR following PCI in CAD patients with reduced LVEF. From 4394 consecutive patients who underwent PCI, a total of 286 patients with reduced LV systolic function (LVEF < 50% at initial left ventriculography) were included in the analysis. LVRR was defined as LV end-systolic volume reduction ≥ 15% and improvement of LVEF ≥ 10% at 6 months follow-up left ventriculography. Patients were divided into LVRR (n = 63) and non-LVRR (n = 223) groups. Multivariate logistic regression analysis revealed that unprotected left main coronary artery (LMCA) intervention was significantly associated with LVRR (P = 0.007, odds ratios [OR] 4.70, 95% confidence interval [CI] 1.54-14.38), while prior PCI (P = 0.001, OR 0.35, 95% CI 0.19-0.66), presence of in-stent restenosis (P = 0.016, OR 0.32, 95% CI 0.12-0.81), and presence of de-novo stenosis (P = 0.038, OR 0.36, 95% CI 0.14-0.95) were negatively associated with LVRR. These data suggest the potential prognostic benefit of unprotected LMCA intervention for LVRR and importance of angiographic follow-up in patients with CAD and LV systolic dysfunction.Entities:
Year: 2021 PMID: 33420237 PMCID: PMC7794568 DOI: 10.1038/s41598-020-80491-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379